3655 results for «321»

Filter By

3655 results

PCR London Valves 2021 Hotlines / Late-Breaking Trials: bRIGHT, EXPAND, CHOICE-MI

21 Nov 2021 – From PCR London Valves

Real-world outcomes for tricuspid edge-to-edge repair, predictors of heart failure hospitalisation and its impact on clinical outcomes, one-year outcomes after TMVI... View part of the Late-Breaking Trials presented during PCR London Valves 2021.

PCR London Valves 2021 Hotlines / Late-Breaking Trials: bRIGHT, EXPAND, CHOICE-MI

Predictability at release means better MR outcomes; PASCAL platform significance in a matched analysis

21 Nov 2021 – From PCR London Valves 2021

Join Peter Lüdike and Philipp Lurz to learn more about about the latest study regarding the predictability of mitral regurgitation reduction using the PASCAL device.

Predictability at release

EAPCI: patient initiatives around the world

22 Nov 2021 – From PCR London Valves 2021

In this session, you can find out more about the EAPCI Valve for Life initiative and what progress has been made in selected countries, as well as other collaborative initiatives across the world.

EAPCI:  patient initiatives around the world

Cases on STEMI

15 Dec 2021 – From GulfPCR-GIM 2021

Watch this session to discover a selection of STEMI cases presented at GulfPCR-GIM 2021, and learn more about: the treatment of intramural haematoma and AMI, the role of plaque modifying device in ACS, the therapeutic strategy for a pan-coronary vulnerability, the importance of stent visualisation to improve...

Cases on STEMI

A mix of cases: HBR in ACS, endovascular venoplasty, carotid artery stenting and TAVI complications

Watch this session to discover various challenging cases presented at GulfPCR-GIM 2021: managing high-bleeding risk in ACS, endovascular venoplasty and stenting of subclavian vein in a patient on prolonged haemodialysis, flow arrest and reversal for carotid artery stenting in patients with high-grade bilateral stenosis, as well as TAVI complications...

Miscellaneous cases

Challenging Cases in Interventional Cardiology

15 Dec 2021 – From GulfPCR-GIM 2021

Watch this session to discover some of the most challenging cases presented at GulfPCR-GIM 2021: a complex coronary cameral fistula, an underexpanded undilatable stent, a rotational atherectomy of left main stem with DK crush stenting using double guiding catheter technique, a cathlab nightmare with stent dislodgement, a dissection of left...

Challenging Cases

Complications: cases of wire entrapment, stent dislodgement, an entangled Impella device and more

16 Dec 2021 – From GulfPCR-GIM 2021

Watch this session to learn how to face various complications, thanks to a selection of cases presented at GulfPCR-GIM 2021: a wire entrapment, a guide-wire fracture, a dissection and a loss of flow, a stent dislodgement, as well as an entangled Impella device. 

Complications

Cases on CTO

16 Dec 2021 – From GulfPCR-GIM 2021

Watch this session to discover 3 CTO cases unveiled at GulfPCR-GIM 2021: a successful CTO left circumflex PCI with periprocedural cardiac tamponade, a dynamic coronary roadmap as a guidance tool in CTO LAD recanalisation, as well as a complicated CTO to right coronary artery.

Cases on CTO

Mitra-leaks

21 Nov 2021 – From PCR London Valves 2021

Visualize a complex mitral paravalvular leak, a complex paravalvular leak closure, or a percutaneous closure of a severe paravalvular leak post TMVR-in-MAC in one sole session from the PCR London Valves 2021!

Mitra-leaks

BYPASS-CTCA: The value of computed tomography cardiac angiography in improving patient satisfaction and reducing contrast load, procedural duration and complications in patients who had previous CABG undergoing invasive coronary angiography

19 Sep 2022

Nicola Ryan provides her take on the BYPASS-CTCA Study which was presented by Daniel A. Jones at the TCT Congress 2022.

It must be understood that the paper has yet to be published for this study therefore all assumptions are based upon the presented data.

Nicola Ryan

Author

Nicola Ryan
Trial Computed Tomography Cardiac Angiography Contrast Load Procedural Duration CABG Invasive Coronary Angiography

BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

07 Nov 2022

Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.

This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...

Nicola Ryan

Author

Nicola Ryan
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

TACSI: Dual or single antiplatelet therapy after CABG in patients with acute coronary syndrome

03 Sep 2025

Aaysha Cader provides her take on TACSI presented by Anders Jeppsson at ESC Congress 2025 in Madrid.

Author

Aaysha Cader
TACSI: Dual or single antiplatelet therapy after CABG in patients with acute coronary syndrome

HOST-EXAM:10-year follow-up of clopidogrel vs aspirin monotherapy in stable CAD after PCI with drug-eluting stent

30 Mar 2026

Nicola Ryan provides her take on the 10-year follow-up of the HOST-EXAM, which was presented by Hyo-Soo Kim at ACC.26 in New Orleans.

Nicola Ryan

Author

Nicola Ryan
10-year follow-up of clopidogrel vs aspirin monotherapy in stable coronary artery disease after percutaneous coronary intervention with drug-eluting stent

Angiography-derived fractional flow reserve versus intravascular ultrasound to guide percutaneous coronary intervention in patients with coronary artery disease: the FLAVOUR II trial

29 Mar 2025

Ali Nazmi Calik provides his take on the FLAVOUR II trial presented by Jian-An Wang at ACC.25 in Chicago.

Author

Ali Nazmi Calik
Angiography-derived fractional flow reserve versus intravascular ultrasound to guide percutaneous coronary intervention in patients with coronary artery disease: the FLAVOUR II trial

NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome

02 Sep 2025

Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...

Daniele Giacoppo

Author

Daniele Giacoppo
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
Didn’t find what you were looking for?